By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Dynacure 

Module 2 du bio-incubateur de l’ESBS, Pôle API.
300 Boulevard Sébastien Brant, CS 10413
Illkirch  Cedex  F-67412  France
Phone: n/a Fax: n/a


SEARCH JOBS

Dynacure is a biotechnology company developing new treatments for patients affected by serious orphan disorders. In its first drug discovery program, Dynacure is focusing on Centronuclear Myopathies (CNM), a rare, debilitating disease affecting children and young adults. Dynacure’s Dyn101 development program is based on the modulation of the expression of the Dynamin 2 protein through the use of an antisense oligonucleotide developed in collaboration with Ionis Pharmaceuticals, the leading biopharmaceutical company in RNA-targeted drug discovery.

YEAR FOUNDED:

2016

LEADERSHIP:

CEO: Stéphane Van Rooijen

COO: Frédéric Legros

Head of Development: Dr Leen Thielemans

Scientific Advisor: Belinda Cowling

Scientific Advisor: Scientific Advisor:

PRODUCTS

Please click here for Dynacure's products.


Key Statistics


Email: info@dynacure.com
Ownership: Private

Web Site: Dynacure
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->